Childhood Rhabdomyosarcoma: Clinical Trials

4 trials for Childhood Rhabdomyosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 unknown. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Recruiting 1, Unknown 1
Phase 21Unknown 1

Follow Childhood Rhabdomyosarcoma: new trials by email Literature Review of Childhood Rhabdomyosarcoma trials Research Report on Childhood Rhabdomyosarcoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas
Fludarabine, Cyclophosphamide, B7-H3-CAR T Cells - Sarcoma, Childhood Osteosarcoma
Phase 1RecruitingSt. Jude Children's Research Hospital422026-01-212026-02-09
Efficacy and Safety of Radiotherapy Combined With Apatinib Mesylate in the Treatment of Rhabdomyosarcoma in Children
Apatinib mesylate tablets, Three-dimensional conformal intensity modulation - Childhood Rhabdomyosarcoma
Phase 1 / Phase 2UnknownXinhua Hospital, Shanghai Jiao Tong University School of Medicine482019-01-012019-03-11
Biomarkers in Tumor Tissue Samples From Younger Patients With Rhabdomyosarcoma
laboratory biomarker analysis - Alveolar Childhood Rhabdomyosarcoma, Childhood Rhabdomyosarcoma
CompletedChildren's Oncology Group772011-12-012016-05-19
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
pharmacological study, laboratory biomarker analysis - Childhood Acute Lymphoblastic Leukemia, Childhood Rhabdomyosarcoma
CompletedChildren's Oncology Group1582008-02-012017-05-17

Narrower conditions

Sarcoma, Ewing (2)  ·  Neuroectodermal Tumors, Primitive, Peripheral (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Sarcoma (1)  ·  Wilms Tumor (1)

Broader conditions

Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Bone Tissue (2)  ·  Neoplasms, Connective Tissue (2)  ·  Neoplasms, Connective and Soft Tissue (2)  ·  Osteosarcoma (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genetic Diseases, Inborn (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Kidney Diseases (1)

Interventions

Cyclophosphamide (1)  ·  Radiotherapy (1)  ·  apatinib (1)  ·  fludarabine (1)

Sponsors

Children's Oncology Group (2)  ·  St. Jude Children's Research Hospital (1)  ·  Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (1)

Countries

United States (3)  ·  Australia (1)  ·  Canada (1)  ·  China (1)

Top investigators

Jeffrey Skolnik (1)  ·  Lee Helman, MD (1)  ·  Mawei Jiang, MD (1)  ·  Rebecca Epperly, MD (1)

Results publications

PMID 32827353

NIH funding

U10CA098543 (1)